Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade
This study seeks to better predict patient-derived tumor responsiveness to immune checkpoint blockade.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/1101059/syndication
- Syndication ID: 17355
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Tuesday, December 19, 2017 at 06:10 PM
- Date Syndication Updated: Monday, August 05, 2019 at 07:40 PM
Embed Code Snippet
To get the embed code snippet please Login.
